Littlejohn & Co’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Littlejohn & Co’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$495K	–	174
2022 Q2	$495K	Hold	50,000	–	–	0.18%	38
2022 Q1	$493K	Hold	50,000	–	–	0.13%	49
2021 Q4	$492K	Hold	50,000	–	–	0.13%	46
2021 Q3	$487K	Hold	50,000	–	–	0.15%	58
2021 Q2	$484K	Buy	+50,000	New	+$486K	0.16%	66

Other funds holding BIOT

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

RiverPark Advisors New York $276M AUM 15.54% 1-Year Est. Return

Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return